Lexicon Pharmaceuticals
LXRX
$1.58
Share price
-0.04%
Change (1 day)
-33.92%
Change (1 year)
Categories
Lexicon Pharmaceuticals (LXRX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.13 B
According to Lexicon Pharmaceuticals 's latest financial reports the company's total liabilities are $0.13 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Lexicon Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $77.17 M | 231.02% |
| 2021-12-31 | $23.31 M | -50.83% |
| 2020-12-31 | $47.41 M | -84.23% |
| 2019-12-31 | $0.30 B | -3.2% |
| 2018-12-31 | $0.31 B | -15.68% |
| 2017-12-31 | $0.36 B | 15.73% |
| 2016-12-31 | $0.31 B | -13.08% |
| 2015-12-31 | $0.36 B | 95.41% |
| 2014-12-31 | $0.18 B | 80.16% |
| 2013-12-31 | $0.10 B | -1.05% |
| 2012-12-31 | $0.10 B | -20.94% |
| 2011-12-31 | $0.13 B | 10.92% |
| 2010-12-31 | $0.11 B | 27.15% |
| 2009-12-31 | $94.26 M | 43.52% |
| 2008-12-31 | $65.68 M | -20.6% |
| 2007-12-31 | $82.72 M | -21.04% |
| 2006-12-31 | $0.10 B | -21.18% |
| 2005-12-31 | $0.13 B | 47.05% |
| 2004-12-31 | $90.38 M | -23.39% |
| 2003-12-31 | $0.11 B | 270.2% |
| 2002-12-31 | $31.87 M | 47.42% |
| 2001-12-31 | $21.61 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $51.88 B | 37,960.73% | 🇺🇸 USA |
 Illumina ILMN | $4.36 B | 3,102.78% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $7.10 B | 5,113.58% | 🇺🇸 USA |
 Ultragenyx RARE | $1.21 B | 791.73% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $86.3 M | -36.69% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.66 B | 384.74% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | $0.53 B | 295.82% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.89 B | 1,286.49% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $46.89 M | -65.60% | 🇺🇸 USA |